YahooAugust 10, 2026 at 10:00 AM NY25 days ago

Lifespan Vision Ventures Leads Remedium Bio's Series A Financing

Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.'s ("Remedium") $10 million Series A financing and has completed the round's initial closing, with participation from Eli Lilly and Company ("Lilly") and HKX Capital. In connection with the financing, Harry Robb of Lifespan Vision Ventures has joined Remedium's Board of Directors.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

LLYEli Lilly and Co1,139.18− 1.76%

Companies in This Story

Related Stories